Alkermes
span multiple neurological diseases independent of underlying pathology many neurological disorders are characterized by synaptic pathology which includes synapse loss abnormal density of dendritic spines aberrant synaptic signaling and plasticity targeting the synapse may slow progression and preserve cognitive and functional abilities in a range of diseases neuropsychiatric neurodegenerative bipolar spectrum disorder frontotemporal dementia disease epilepsy schizophrenia disease major depressive disorder disease cochlear retinal autism spectrum disorders syndrome fragile syndrome dementia in down syndrome tuberous sclerosis complex syndrome | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
114 of 144
Related slides by other companies
Albireo Pharma
Results
October 2022
syndrome is devastating disease a | Albireo Pharma
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io